Biontech Se share price logo

Biontech Se Share Price

NASDAQ: BNTX

Large Cap

$89.31

as on

Biontech Se Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $87.21
    $89.56
    downward going graph

    2.35%

    Downside

    0.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $79.52
    $124.00
    downward going graph

    10.96%

    Downside

    38.84%

    Upside

    downward going graph

Biontech Se share price movements today

Previous Close
$89.31
Open
$89.00
Volume
766.0K
Day's Low - High
$87.21 - $89.56
52 Week Low - High
$79.52 - $124.00

Biontech Se Historical Returns

1 Month Return
-18.95 %
3 Month Return
-3.49 %
1 Year Return
-6.41 %
3 Year Return
-33.05 %
5 Year Return
-17.03 %

Biontech Se Stock Fundamentals & Key Indicators

Check Biontech Se market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$22.4B

EPS (TTM)

-4.0895

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.43%

PE Ratio (TTM)

-40.18

Industry PE ratio

17.63179487179487

PEG Ratio

0.0449

EBITDA

-1.1B

Revenue (TTM)

2.9B

Profit Margin

-39.59%

Return On Equity TTM

-5.88%

Biontech Se Stock Valuation

Track how Biontech Se P/E has moved over time to understand its valuation trends.

Biontech Se in the last 5 years

  • Overview

  • Trends

Lowest (-69.14x)

June 30, 2025

Today (-40.18x)

March 21, 2026

Industry (17.63x)

March 21, 2026

Highest (26.31x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -40.18x

Biontech Se vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biontech Se with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Biontech Se image
Biontech Se
BUY$22.4B-17.03%-40.18-39.59%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.3B116.54%133.528.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$116.3B110.08%29.9432.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA114.935.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B54.71%17.831.41%

Stock Returns calculator for Biontech Se Stock including INR - Dollar returns

The Biontech Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Biontech Se investment value today

Current value as on today

₹1,03,081

Returns

₹3,081

(+3.08%)

Returns from Biontech Se Stock

₹6,364 (-6.36%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Biontech Se Stock

Based on 24 analysts

BUY

54.17%

Buy

37.50%

Hold

8.33%

Sell

Based on 24 analysts, 54.17% of analysts recommend a 'BUY' rating for Biontech Se. Average target price of $131.68

Biontech Se Share Price Target

Get share price movements and forecasts by analysts on Biontech Se.

What analysts predicted

32.18%UPSIDE

Target Price

$131.68

Current Price

$89.31

Analyzed by

24 Analysts

Target

$131.68

Biontech Se target price $131.68, a slight upside of 32.18% compared to current price of $89.31. According to 24 analysts rating.

Biontech Se Stock’s Investor Sentiment and Interest

Investment in Biontech Se Shares on INDmoney has grown by 328.00% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:328.00% versus previous 30 day period

Search interest for Biontech Se Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:23% versus previous 30 day period

Biontech Se Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
955
1,613
203
138
1,382
1,245
197
260
1,518
898
Gross Profit
783
1,418
139
74
1,183
990
107
184
1,370
568
Operating Income
73
526
-507
-966
10
148
-534
-501
-46
-230
EBITDA
270
455
-288
-752
211
464
-368
-348
149
-67
Interest Expense
2
18
4
7
5
7
6
3
0
6
Depreciation
41
78
38
49
44
165
42
51
124
164
Income Before Tax
227
663
-331
-805
158
301
-445
-402
24
-225
Income Tax Expense
66
205
-16
2
-39
41
-29
-16
53
76
Net Income
171
499
-342
-869
219
271
-449
-386
-28
-302
Net Profit Margin
17.94%
30.96%
-167.96%
-627.66%
15.91%
21.81%
-227.46%
-148.24%
-1.89%
-33.61%

Biontech Se Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
72
145
120
586
21,452
18,318
4,166
2,878
2,756
Gross Profit
61
129
101
514
18,161
15,149
3,511
2,311
2,140
Operating Income
-61
-53
-181
-82
15,283
12,642
690
-1,314
-623
EBITDA
-74
-23
-143
-105
15,002
13,096
1,377
-367
-256
Interest Expense
0
1
1
1
5
15
7
13
13
Depreciation
10
21
33
38
75
123
183
298
382
Income Before Tax
-85
-47
-179
-145
15,046
12,954
1,186
-677
-1,009
Income Tax Expense
0
0
0
-161
4,753
3,519
255
-12
81
Net Income
-101
-54
-199
18
11,635
9,983
1,014
-696
-1,091
Net Profit Margin
-139.05%
-37.64%
-164.92%
3.15%
54.24%
54.50%
24.36%
-24.18%
-39.59%

Biontech Se Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
492
-341
-869
217
276
-437
-438
-33
-302
Operating Cash Flow
850
-344
1,759
-687
-501
-821
132
854
299
Investing Cash Flow
-2,835
-2,501
-248
-162
649
1,312
-26
-995
-2,626
Financing Cash Flow
-3
-8
-24
-8
-8
-14
-14
-14
-13
Change in Cash
-1,404
-3,189
1,426
-379
-633
893
1,053
-195
-2,421

Biontech Se Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-47
-179
-145
15,046
12,954
1,186
-677
-1,091
Operating Cash Flow
-58
-198
-13
889
13,577
5,371
207
438
Investing Cash Flow
-67
-77
-144
-566
-35
-6,954
-2,081
-2,371
Financing Cash Flow
365
383
894
94
-1,419
-778
-45
-50
Change in Cash
239
107
691
482
12,182
-2,211
-1,901
-931

Global Institutional Holdings in Biontech Se

Funds
Holdings
Temasek Holdings Ltd.
0.6%
Jane Street Group LLC
0.54%
Baillie Gifford & Co Limited.
0.5%
Bank of America Corp
0.23%
Bank of New York Mellon Corp
0.23%
See all

Biontech Se News & Key Events

  • img

    Today's Timeline - 10 March

    Tue, 10:06 PM

    -

    BioNTech co-founders Sahin and Türeci to leave for a new mRNA venture, causing shares to drop over 20%.

Insights on Biontech Se

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Biontech Se has experienced a drawdown of -33.2%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 30.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 17.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.51B → 898.89M (in $), with an average decrease of 40.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, BNTX stock has moved down by -19.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -28.7M → -302.13M (in $), with an average decrease of 952.8% per quarter

About Biontech Se

everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we’re working on revolutionary approaches in the fight against cancer and other diseases. over 400 dedicated, passionate pioneers achieve sensational success and promising breakthroughs time and again by forging new paths – and ensure people all around the world have hope for the future. you too can become a pioneer! http://biontech.de/ http://biontech.de/imprint/
OrganisationBiontech Se
HeadquartersAn der Goldgrube 12, Mainz, Germany, 55131
IndustryHealth Technology
CEODr. Ugur Sahin M.D.
E-voting on sharesClick here to vote

Key Management of Biontech Se

Name

Title

Dr. Ugur Sahin M.D.

Co-Founder, CEO & Chair of the Management Board

Dr. Ozlem Tureci M.D.

Co-Founder, Chief Medical Officer & Member of Management Board

Dr. Sierk Pötting Ph.D.

MD, COO & Member of Management Board

Dr. James Timothy Patrick Ryan Ph.D.

Chief Legal & Business Officer and Member of the Management Board

Mr. Douglas Maffei Ph.D.

Vice President of Strategy & Investor Relations

Jasmina Alatovic

Vice President Corporate Communications

Mr. Ramon Zapata-Gomez

CFO & Member of Management Board

Ms. Annemarie Hanekamp

Chief Commercial Officer & Member of Management Board

Ms. Kylie Jimenez

Chief People Officer & Member of Management Board

Ms. Lisa Birringer

Senior Vice President of Global Financial Reporting & Accounting

FAQs

What is Biontech Se share price today?

Biontech Se share price today is $89.31 as on at the close of the market. Biontech Se share today touched a day high of $89.56 and a low of $87.21.

What is the 52 week high and 52 week low for Biontech Se share?

Biontech Se share touched a 52 week high of $124 on and a 52 week low of $79.52 on . Biontech Se stock price today i.e. is closed at $89.31,which is 27.98% down from its 52 week high and 12.31% up from its 52 week low.

What is Biontech Se's market capitalisation today?

Biontech Se market capitalisation is $0.02T as on .

How to invest in Biontech Se Stock (BNTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biontech Se on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biontech Se Shares that will get you 0.0168 shares as per Biontech Se share price of $89.31 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Biontech Se Stock (BNTX) from India?

Indian investors can start investing in Biontech Se (BNTX) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Biontech Se stock (as per the Rupee-Dollar exchange rate as on ). Based on Biontech Se share’s latest price of $89.31 as on March 21, 2026 at 1:29 am IST, you will get 0.1120 shares of Biontech Se. Learn more about fractional shares .

What are the returns that Biontech Se has given to Indian investors in the last 5 years?

Biontech Se stock has given -17.03% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?